About us
About us
Futura Medical is based in Guildford, United Kingdom (“UK”) and is listed on the AIM market of the London Stock Exchange. We are an agile, driven and committed team with extensive experience in the research, development and commercialisation of consumer health products in all of the key global consumer healthcare markets.
Explore this section
Who we are
Our business model
Board of directors
Eroxon^®
Eroxon^®
Our lead product is Eroxon^®a clinically proven breakthrough treatment for erectile dysfunction
What is Eroxon^®
Eroxon^® availability at a glance
Clinical data
Marketplace
Commercial partners
Commercialisation
Eroxon^® FAQs
PIPELINE
PIPELINE
Futura has two new projects in its development pipeline, Eroxon^® Intense for the treatment of erectile dysfunction and WSD4000 for the treatment of symptoms of impaired sexual response and function in women
Eroxon^® Intense
WSD4000 - For the treatment of symptoms of impaired sexual response and function in women
Investor FAQs
Investor centre
Investor centre
Futura Medical specialises in the development and global commercialisation of innovative consumer-focused sexual health products. Our lead projects are Eroxon^® (available commercially) and Eroxon^® Intense and WSD4000 (both in-development). Our core strengths lie in our expertise in research and development, regulatory and business development in the sexual health market.
WEBCASTS
Explore this section
Share price chart
Strategic review & FSP
Corporate documentation
Videos and webcasts
Videos and webcasts
Videos
Webcasts
RNS
Alert service
Shareholder centre
Shareholder centre
Investor contacts and advisors
Shareholder information
Financial calendar
Investor FAQs
Analyst Research
Corporate Governance
AIM rule 26
Media
Media
This section contains the latest RNS, news and videos.
Explore this section
Event calendar
RNS
Videos
Alert service
Contact us

About us
Eroxon^®
PIPELINE
Investor centre
Media
Contact us

Share price chart

Home
Investor centre
Share price chart

Interactive chart

Company	FUM
Market	LON
Currency	GBX
Price	0.22p
Marketcap	£3.20M
Number of Shares	1,482,327,755*
Bid	0.00
Ask	0.00
Volume	2,975,145
Change	-0.01
% Change	-6.09%%
Previous Close	0.22
Today's Open	0.23
Today's High	0.24
Today's Low	0.21
Today's Trades	42
52 Week High	3.21
52 Week Low	0.18

* Shares in issue number updated periodically. Please check regulatory announcements for the most up to date position.

You may also be interested in

Corporate documentation

RNS

Investor FAQs

Sitemap
Contact us
Accessibility
Terms of use
Privacy & cookies policies

Designed and developed by
jonesandpalmer.co.uk